Related Experiment Video
Updated: May 24, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Nitric oxide in neonatal hypoxemic respiratory failure
Maria Carmela Muraca1, Simona Negro, Bo Sun
1Departments of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy.
Inhaled nitric oxide (iNO) helps treat newborn hypoxemic respiratory failure like PPHN and improves oxygenation in meconial aspiration syndrome. However, iNO shows limited benefits for preterm infants and does not reduce mortality in PPHN patients.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Pharmacology
Background:
- Nitric oxide (NO) is a key vasodilator regulating pulmonary vascular tone.
- Persistent Pulmonary Hypertension of the Newborn (PPHN) involves failure of pulmonary vascular adaptation, leading to high resistance.
- NO therapy is explored for hypoxemic respiratory failure, including PPHN, meconial aspiration syndrome, and congenital diaphragmatic hernia (CDH).
Purpose of the Study:
- To review the role and efficacy of inhaled nitric oxide (iNO) in treating various neonatal respiratory conditions.
- To assess iNO's impact on mortality, need for ECMO, and oxygenation in newborns with PPHN, MAS, and CDH.
- To evaluate the current evidence for iNO use in preterm infants with respiratory failure.
Main Methods:
- Literature review and synthesis of existing studies on iNO therapy in neonatal respiratory failure.
- Analysis of clinical outcomes including mortality, need for extracorporeal membrane oxygenation (ECMO), and oxygenation.
- Examination of iNO's efficacy in specific neonatal conditions like PPHN, meconial aspiration syndrome, and CDH.
Main Results:
- iNO therapy can decrease the need for ECMO in PPHN and improve oxygenation in meconial aspiration syndrome, but has not reduced mortality.
- Congenital diaphragmatic hernia patients may show oxygenation improvement with iNO, but are often poor responders; iNO may aid presurgical stabilization.
- Current evidence does not support routine or rescue use of iNO in preterm infants due to differing pathophysiology and risks.
Conclusions:
- Inhaled nitric oxide is a valuable adjunct in managing specific neonatal respiratory conditions like PPHN and MAS, primarily by improving oxygenation and reducing ECMO reliance.
- While beneficial in certain contexts, iNO's role in congenital diaphragmatic hernia is variable, and its use in preterm infants is not currently supported by evidence.
- Further research may clarify optimal iNO strategies, but current guidelines emphasize caution, especially in vulnerable preterm populations.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Nitric Oxide Signaling Pathway
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
